Free Trial
NASDAQ:RAPP

Rapport Therapeutics 8/8/2024 Earnings Report

Rapport Therapeutics logo
$10.22 -0.17 (-1.64%)
Closing price 05/7/2025 04:00 PM Eastern
Extended Trading
$10.22 +0.00 (+0.05%)
As of 05/7/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rapport Therapeutics EPS Results

Actual EPS
-$1.70
Consensus EPS
-$0.68
Beat/Miss
Missed by -$1.02
One Year Ago EPS
N/A

Rapport Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rapport Therapeutics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Rapport Therapeutics' Q1 2025 earnings is scheduled for Monday, June 2, 2025

Conference Call Resources

Rapport Therapeutics Earnings Headlines

Mise à disposition du rapport financier annuel 2024
Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.
Rapport Therapeutics initiated with an Outperform at Citizens JMP
See More Rapport Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rapport Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapport Therapeutics and other key companies, straight to your email.

About Rapport Therapeutics

Rapport Therapeutics (NASDAQ:RAPP) Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.

View Rapport Therapeutics Profile

More Earnings Resources from MarketBeat